BioSpace News Archive

GenBody America, LLC, the U.S. affiliate of GenBody, Inc., today announced that the U.S. Food and Drug Administration (FDA) has made an amendment to the emergency use authorization for the GenBody COVID-19 Ag kit, which has been updated to include prefilled individual reagent tubes for each test device.

Vida Health, a leader in virtual cardiometabolic healthcare, is hiring a team of endocrinologists as it continues to expand towards higher acuity treatments.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced the company’s official listing on the Main Board of the Stock Exchange of Hong Kong.

Coya Therapeutics, Inc. (“Coya”), a clinical-stage biotechnology company developing multiple approaches that aim to enhance regulatory T cells (Tregs) function, including allogeneic Treg-derived exosome therapeutics and novel biologics, today announced the publication of the Phase 2a clinical trial data for its first-in-class Treg cell therapy product candidate, COYA 101.

Neogen Corporation announced that it has completed the previously announced merger with 3M’s Food Safety business to create an innovative leader in the food safety sector with a comprehensive product range and a strategic focus on the category’s long-term growth opportunities.

Thryv Therapeutics Inc. is pleased to announce the appointment of Dr. Debra Odink to President and Chief Development Officer of the company and the addition of Dr. Shi Yin Foo to its Board of Directors.

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a 30-µg booster dose of their Omicron BA.1 Bivalent COVID-19 Vaccine (COMIRNATY® Original/Omicron BA.1 15/15 µg) has been recommended for conditional marketing authorization (cMA) by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for individuals 12 years and older.

UCB, a global biopharmaceutical company, announced that it will present 20 abstracts across its dermatology portfolio at the 31st European Academy of Dermatology and Venereology Congress in Milan, Italy, September 7-10.

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to two upcoming webcasts of Pfizer discussions at healthcare conferences.

The Lubrizol Corporation, a Berkshire Hathaway Company, announced that Rebecca Liebert has been named the company’s President and CEO, effective October 3, 2022.